CJC-1295 (with DAC)
Also known as: CJC-1295 DAC, Modified GRF(1-29) with DAC
How It Works
Growth hormone releasing hormone (GHRH) analog with Drug Affinity Complex (DAC) that extends half-life to ~8 days. Stimulates pituitary to release GH in a pulsatile fashion.
What It's Used For
Administration
Safety & Side Effects
Possible Side Effects
- ⚠Water retention
- ⚠Tingling/numbness in extremities
- ⚠Increased hunger
- ⚠Flushing
Contraindications
- ✘Active cancer
- ✘Pregnancy
- ✘Pituitary disorders
- ✘Diabetes (monitor closely)
Research Summary
Modified GHRH analog shown to increase IGF-1 levels by 200-300% in clinical studies. DAC modification extends half-life allowing less frequent dosing.
References
- Teichman SL et al. J Clin Endocrinol Metab. 2006
Legal & Availability
Research chemical / Compounding pharmacy with prescription
Dosing Protocol
Stacks Well With
Ipamorelin
Anti-aging, Fat loss
MK-677 (Ibutamoren)
GH elevation, Sleep quality
BPC-157
Injury repair, Gut healing
Full stacking protocols and cycling schedules available with Pro subscription.
Is CJC-1295 (with DAC) Right for You?
Our AI analyzes your symptoms, labs, and medical history to determine if this peptide fits your protocol — and at what dose.
Is CJC-1295 (with DAC) right for you?
Get a free personalized analysis based on your symptoms and goals — delivered to your inbox.
This information is for educational purposes only and is not medical advice. Do not use any peptide without consulting a qualified healthcare provider. BioRoot AI is a clinical decision support tool — not a medical provider.